Efficacy and safety of pentosan polysulfate therapy in patients with interstitial cystitis for relief of lower urinary tract symptoms: 15-year single center experience
PPS provides clinical benefits in urinary symptoms voiding symptoms and QoL over time, arriving plateau within 3 months. Such benefits based on the IPSS tend to be more evident in younger patients, suggesting that PPS mostly benefits early treatment if suspected for IC/BPS.
Authors
- Byeongdo Song (ORCID: https://orcid.org/0000-0003-3961-1258)
- Hwanik Kim (ORCID: https://orcid.org/0000-0001-5201-2490)
- Seong Jin Jeong (ORCID: https://orcid.org/0000-0002-3580-1452)
- Gyoohwan Jung (ORCID: https://orcid.org/0000-0002-1602-0036)
- Sung Kyu Hong (ORCID: https://orcid.org/0000-0002-8344-6774)
- Sang Hun Song (ORCID: https://orcid.org/0000-0003-3016-0032)
- Jong Ho Park (ORCID: https://orcid.org/0009-0004-2332-0012)
Institutions
- Seoul National University (KR)
- Seoul National University Bundang Hospital (KR)
- Hanyang University Guri Hospital (KR)
- Hanyang University Seoul Hospital (KR)
- Hallym University Sacred Heart Hospital (KR)
Publication Details
- Journal
- Prostate International
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1016/j.prnil.2025.05.001
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Seoul National University Bundang Hospital